Serum cytokine profile in the subclinical form of visceral leishmaniasis

Brazilian Journal of Medical and Biological Research

Volumn 37, Issue 1, 2004, Pages 129-136

  Gama, M E A ^a,b   Costa, J M L ^a   Pereira, J C R ^c   Gomes, C M C ^b   Corbett, C E P ^b  

^a FEDERAL UNIVERSITY OF MARANHÃO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c INSTITUTO DANTE PAZZANESE DE CARDIOLOGIA   (Brazil)

Author keywords

Cytokine levels; Immunological aspects; Oligosymptomatic form; Subclinical form; Visceral leishmaniasis

Indexed keywords

BIOLOGICAL MARKER; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BLOOD LEVEL; BRAZIL; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DISCRIMINANT ANALYSIS; ENZYME IMMUNOASSAY; FOLLOW UP; HUMAN; INFANT; INFECTION RESISTANCE; INFECTION SENSITIVITY; LEISHMANIA; MAJOR CLINICAL STUDY; PRESCHOOL CHILD; SYMPTOMATOLOGY; TH1 CELL; TH2 CELL; VISCERAL LEISHMANIASIS;

LEISHMANIA MAJOR; PROTOZOA;

EID: 1242284661     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2004000100018     Document Type: Article

References (35)

1. World Health Organization (1991). Control of Leishmaniasis. Report of a WHO Expert Committee. Technical Report Series, Geneva, Switzerland.
2. Ministério da Saúde, Brasil (1996). Controle, Diagnóstico e Tratamento de Leishmaniose Visceral (Calazar) - Normas Técnicas. Fundacão Nacional de Saúde, Brasília, DF, Brazil.
3. Bittencourt A & Barral-Netto M (1995). Leishmaniasis. In: Doeer W (Editor), Tropical Pathology. Springer-Verlag, Berlin, Germany, 597-651.
4. Holaday B (2000). Role of CD8+ T cells in endogenous interleukin-10 secretion associated with visceral leishmaniasis. Memórias do Instituto Oswaldo Cruz, 95: 217-220.
5. Liew F, Millott S, Parkinson C, Palmer R & Mancada S (1990). Macrophage killing of Leishmania parasites in vivo is mediated by nitric oxide from L-arginine. Journal of Immunology, 144: 4794-4797.
6. Barral-Netto M, Badaró B & Barral A (1991). Tumor necrosis factor (cachectin) in human visceral leishmaniasis. Journal of Infectious Diseases, 163: 853-857.
7. Bacellar O, Barral-Netto M, Badaró R & Carvalho E (1991). Gamma interferon production by lymphocytes from children infected with L. chagasi. Brazilian Journal of Medical and Biological Research, 24: 791-795.
8. Carvalho E, Bacellar O, Brownell C, Regis I, Coffman R & Reed S (1994). Restoration of IFN-γ production and lymphocyte proliferation in visceral leishmaniasis. Journal of Immunology, 152: 5949-5956.
9. Carvalho E, Almeida R & Jesus A (1995). Imunidade e infecção. Medicina, 28: 253-283.
10. Ghalib H, Wittle J & Kubin M (1995) IL-12 enhances Th1-type responses in human Leishmania donovani infections. Journal of Immunology, 154: 4623-4629.
11. Sang D, Ouma J & John C (1999). Increased levels of soluble interleukin-4 receptor in the sera of patients with visceral leishmaniasis. Journal of Infectious Diseases, 179: 743-746.
12. Carvalho E, Barral A & Pedral-Sampaio D (1992). Immunological markers of clinical evolution in children recently infected with Leishmania donovani chagasi. Journal of Infectious Diseases, 165: 535-540.
13. Gama M (2001). Perfil clínico e laboratorial da forma oligossintomática da leishmaniose visceral americana. Doctoral thesis, Departamento de Patologia, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brazil.
14. Caldas A, Silva D, Pereira C & Costa JML (2001). Infecção por Leishmania (Leishmania) chagasi em crianças de uma área endêmica de leishmaniose visceral americana, na Ilha de São Luís, Maranhão, Brasil. Revista da Sociedade Brasileira de Medicina Tropical, 34: 445-451.
15. Badaró R (1988). Progressos nas pesquisas de leishmaniose visceral na área de Jacobina, Bahia 1934-1989. Revista da Sociedade Brasileira de Medicina Tropical, 21: 159-164.
16. D'Oliveira Jr A, Costa S, Barbosa A, Orge M & Carvalho E (1997). Asymptomatic Leishmania chagasi infection in relatives and neighbors of patients with visceral leishmaniasis. Memórias do Instituto, Oswaldo Cruz, 92: 15-20.
17. Mattner F, Padova K & Alber G (1997). Interleukin-12 is indispensable for protective immunity against Leishmania major. Infection and Immunity, 65: 4378-4383.
18. Bogdan C & Rollinghoff M (1998). The immune response to Leishmania: mechanisms of parasite control and evasion. International Journal for Parasitology, 28: 121-134.
19. Salomão R, Castelo Filho A, Medeiros I & Sicolo M (1996). Plasma levels of tumor necrosis factor-α in patients with visceral leishmaniasis: association with activity of the disease and clinical remission following antimonial therapy. Revista do Instituto de Medicina Tropical de São Paulo, 38: 113-118.
20. Medeiros I (1997). Avaliação prospectiva dos níveis de gama interferon, interleucina-10 e fator de necrose tumoral-α antes, durante e ao final da terapêutica da leishmaniose visceral. Doctoral thesis, Escola Paulista de Medicina, São Paulo, SP, Brazil.
21. Babaloo Z, Kaye P & Eslami M (2001). Interleukin-13 in Iranian patients with visceral leishmaniasis: relationship to other Th2 and Th1 cytokines. Transactions of the Royal Society of Tropical Medicine and Hygiene, 95: 85-88.
22. Zwingenberger K, Harms G, Pedrosa C, Omena S, Sandkamp B & Neifer S (1990). Determinants of the immune response in visceral leishmaniasis: evidence for predominance of endogenous interleukin-4 over interferon-γ production. Clinical Immunology and Immunopathology, 57: 242-249.
23. Sundar S, Reed S, Sharma S, Mehrotra A & Murray H (1997). Circulating T helper 1 (Th1) cell- and Th2 cell-associated cytokines in Indian patients with visceral leishmaniasis. American Journal of Tropical Medicine and Hygiene, 56: 522-525.
24. Badaró R, Jones T & Carvalho E (1986). New perspectives on a subclinical form of visceral leishmaniasis. Journal of Infectious Diseases, 154: 1003-1011.
25. Holaday B, Pompeu M, Evans T et al. (1993). Correlates of Leishmania-specific immunity in the clinical spectrum of infection with Leishmania chagasi. Journal of Infectious Diseases, 167: 411-417.
26. Leishman W (1976). Handbuch der Tropenkrankheiten. 2nd edn.
27. Leipzig 1906 apud Pampiglione S, Manson-Bahr P, Giungi F, Giunti G, Parenti A & Troti G. Studies on Mediterranean leishmaniasis II. Asymptomatic cases of visceral leishmaniasis. Transactions of the Royal Society of Tropical Medicine and Hygiene, 68: 349-358.
28. Guerra M, Furtado T, Barros G, Sessa P & Daher V (1985). Infecção subclínica na leishmaniose tegumentar. Anais Brasileiros; de Dermatologia, 60: 365-369.
29. Uyemura K, Pirmez C, Sieling P, Kiene K, Paes-Oliveira M & Modlin R (1993). CD4+ type 1 and CD8+ type 2 T cell subsets in human leishmaniasis have distinct T cell receptor repertoires. Journal of Immunology, 151: 7095-7104.
30. Oppenheim J, Ruscetti F & Faltynek C (1991). Citocinas. In: Stiles D & Abba T (Editors), Imunologia Básica. Revinter, Rio de Janeiro, RJ, Brazil, 61-76.
31. Stevens D (1995). Cytokines: an updated compendium. Current Opinion in Infectious Diseases, 8: 175-180.
32. Janeway C & Travers P (1997). Imunobiologia: O Sistema Imunológico na Saúde e na Doença. Artes Médicas, Porto Alegre, RS, Brazil.
33. Ghalib H, Piuvezam M, Skeiky Y, Siddig M, Hashim FA, el-Hassan AM, Russo DM & Reed SG (1993). Interleukin 10 production correlates with pathology in human Leishmania donovani infection. Journal of Clinical Investigation, 92: 324-329.
34. Raziuddin S, Abdalla R, El-Awad E & Al-Janadi M (1994). Immunoregulatory and proinflammatory cytokine production in visceral and cutaneous leishmaniasis. Journal of Infectious Diseases, 170: 1037-1040.
35. Kemp K, Kemp M, Kharazmi A, Ismail A, Kurtzhals JA, Hviid L & Theander TG (1999). Leishmania-specific T cells expressing interferon-gamma (IFN-gamma) and IL-10 upon activation are expanded in individuals cured of visceral leishmaniasis. Clinical and Experimental Immunology, 116: 500-504.